Related Experiment Video
Updated: May 20, 2025

10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
17.7K
Putting Patients First: Pragmatic Trials in Gynecologic Oncology
Laura Hopkins1, Mark Clemons2, Karen Bemister3
1Department of Oncology, University of Saskatchewan, Saskatoon, SK S7V 4H4, Canada.
Current Oncology (Toronto, Ont.)
|March 26, 2025
Summary
A workshop launched an initiative to develop pragmatic clinical trials (PCTs) in Canadian gynecologic oncology. Patient input was crucial in designing trials focused on real-world effectiveness and patient-centered outcomes.
Area of Science:
- Oncology
- Clinical Trials
- Health Services Research
Background:
- The Society of Gynecologic Oncology of Canada convened an interdisciplinary workshop in November 2024.
- The workshop aimed to establish an initiative for developing and promoting pragmatic clinical trials (PCTs) in Canadian gynecologic oncology research.
Purpose of the Study:
- To emphasize foundational elements of pragmatism in PCTs.
- To demonstrate the real-world effectiveness of interventions across diverse patient populations.
- To present how PCT outcomes can influence clinical decision-making and health policy based on patient-prioritized outcomes.
Main Methods:
- Brought together diverse stakeholders: ovarian cancer patients, patient advocates, PCT experts, gynecologic oncologists, medical oncologists, and clinical fellows.
- Focused on the core principles of pragmatism and the goal of PCTs.
- Incorporated patient and advocate input in co-designing PCT protocols.
Main Results:
- Several new PCT proposals were developed, guided by patient input.
- Emphasis was placed on patient-centered outcomes such as overall survival and quality of life.
- The workshop highlighted the essential role of patients and advocates in research design.
Conclusions:
- The workshop successfully initiated a collaborative effort to advance PCTs in gynecologic oncology.
- Patient engagement is vital for ensuring PCTs address relevant questions and outcomes.
- Future educational initiatives are planned to further involve clinical investigators in PCT development.

